Tag: bioequivalence issues
FDA Deficiency Letters in Generic Drug Applications: Common Findings and How to Avoid Them
Learn why FDA sends deficiency letters for generic drug applications, the top reasons including dissolution failures and unqualified impurities, and actionable steps to avoid delays and costly rejections.
Read More